<div id="readability-page-1">10:43 AM EST, 01/12/2026 (MT Newswires) -- (Updated headline and first paragraph)The French finance ministry said that Eli Lilly ( LLY ) has not contacted them about a potential bid to acquire Abivax ( ABVX ), which is compulsory for pharmaceutical companies under the country's investment screening rules, Bloomberg reported Monday.Abivax ( ABVX ) shares were up nearly 32% in recent premarket activity Monday after French media outlet La Lettre reported that Eli Lilly ( LLY ) was preparing a 15-billion-euro ($17.53 billion) takeover offer for the biotech startup.Before submitting a formal offer to Abivax's ( ABVX ) board, Lilly is waiting for a confirmation from France's finance ministry on whether the potential takeover would be subject to local foreign investment controls, according to a Google-translated text of the article.Abivax ( ABVX ) and Lilly didn't immediately respond to MT Newswires' requests for comment.Price: 1072.51, Change: +8.95, Percent Change: +0.84 MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

礼来

ABVX

法国财政部表示，礼来尚未就收购 Abivax 事宜与他们联系，而根据当地投资审查规则，这是必需的。在有关礼来可能提出 150 亿欧元收购要约的报道后，Abivax 的股价上涨了近 32%。在正式提出要约之前，礼来正在等待财政部确认此次收购是否会受到外资投资管制的限制

更新：法国政府称礼来公司未就收购 Abivax 进行任何联系